Quotient Sciences

Activities: Manufacturing Ingredients Drug Delivery Research & Development Dosage Forms

Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway for small-molecule and peptide drug programs. We cut through silos across a range of drug development capabilities, saving precious time and money in getting drugs to patients. With drug development and clinical testing facilities located in both the US and the UK, we work with customers in a flexible way by either designing and delivering fully integrated programs at each stage of the development lifecycle, or by providing support through tailored individual services in Drug Substance Synthesis and Manufacturing, Formulation Development, Clinical Trial Manufacturing, Clinical Pharmacology, Bioanalysis, Data Sciences, Commercial Manufacturing, and Drug Development Consulting.

Trending Articles

  1. Sanofi's Novolog biosimilar Merilog gets the FDA green light The biosimilar improves glycaemic control in diabetic patients by lowering blood sugar spikes, and is the first fast-acting insulin analog to be approved in the US
  2. Key advantages of vacuum tray drying Vacuum tray drying is a tried-and-trusted method in critical industries, like biotech and pharmaceutical manufacturing. It lends itself to high-throughput, batch-drying...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Driving efficiency gains: the value of IIOT and connected applications Real-time data collection and analysis are at the heart of IIoT; by continuously monitoring equipment and production processes, manufacturers can detect anomalies, predict...
  4. SK pharmteco opens US HPAPI analytical testing laboratory The CDMO offers a range of analytical services at the site, including UPLC, gas chromatography and colourimetric/volumetric water titration
  5. C&M Scientific acquires scientific equipment specialist, Radison Services Through this acquisition, the service arm of the Scientific Laboratory Supplies Group will expand its reach across the UK and Ireland

Upcoming event

Pharma Packaging and Labelling Forum

5–6 March 2025 | Conference | San Diego, US See all

Related Content

Manufacturing

Manufacturing Chemist Stand Side with Quotient Sciences

We discover what exhibitors at CPHI Milan 2024 are showcasing LIVE!
Research & Development

Quotient Sciences and Medicines for Malaria Venture announce first-ever long-acting injectable for malaria prevention

First-in-human study explores a single injection that provides 3 months of protection
Manufacturing

Quotient Sciences and Vasa Therapeutics announce dosing of first subjects in VS-041 novel heart failure trial

The trial is designed to evaluate the safety, tolerability, and pharmacokinetics of VS-041 in healthy volunteers
Ingredients

The promising future of GLP-1s and oral peptides

Dr Andy Lewis, Chief Scientific Officer at Quotient Sciences, examines the trends driving the adoption of oral peptide products and discusses strategies to overcome the development challenges associated with effective delivery
Manufacturing

Post-CPHI roundup: novel trends and tech in the CDMO space

Annabel Kartal-Allen (AKA) spoke to Thierry Van Nieuwenhove (TVN), CEO of Quotient Sciences, to discuss the impact of next-generation oral dosage therapeutics, AI technologies and the company’s drug development platform on the pharmaceutical industry

Quotient Sciences appoints three new executive members

The appointments include Andrew Lewis as Chief Scientific Officer, Kieron Hall as Chief Marketing Officer, and Eric Bironneau as Chief Business Officer
Manufacturing

EnergiVault trial delivers peak performance

Full-scale testing of the EnergiVault cold thermal energy storage system from Organic Heat Exchangers (O-Hx) has seen performance exceed expectations in areas including peak load support, resilience and reliability
Subscribe now